Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy

AIMS: Exogenous atrial natriuretic peptide (ANP) may be a logical treatment for heart failure (HF) patients with ANP deficiency. Lower ANP concentrations may result from HF with preserved ejection fraction (HFpEF), which also results in lower brain natriuretic peptide levels in HFpEF relative to HF...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Shingo, Nakazawa, Gaku, Ohno, Yohei, Ishihara, Mai, Sakai, Katsuaki, Nakamura, Norihito, Murakami, Tsutomu, Natsumeda, Makoto, Kabuki, Takayuki, Shibata, Atsushi, Kida, Keisuke, Konishi, Masaaki, Ishii, Shunsuke, Ikeda, Takanori, Ikari, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754892/
https://www.ncbi.nlm.nih.gov/pubmed/33037750
http://dx.doi.org/10.1002/ehf2.13042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754892/
https://www.ncbi.nlm.nih.gov/pubmed/33037750
http://dx.doi.org/10.1002/ehf2.13042

Ejemplares similares